Position article and guidelines
Alessandro Fiocchi1†, Ruby Pawankar2†, Carlos Cuello-Garcia34, Kangmo Ahn5, Suleiman Al-Hammadi6, Arnav Agarwal37, Kirsten Beyer8, Wesley Burks9, Giorgio W Canonica10,Motohiro Ebisawa11, Shreyas Gandhi37, Rose Kamenwa12, Bee Wah Lee13, Haiqi Li14,Susan Prescott15, John J Riva16, Lanny Rosenwasser17, Hugh Sampson18, Michael Spigler19, Luigi Terracciano20, Andrea Vereda-Ortiz22, Susan Waserman21, Juan José Yepes-Nuñez3, Jan L Brożek213* and Holger J Schünemann213
Published: 27 January 2015
Abstract
Background
Prevalence of allergic diseases in infants, whose parents and siblings do not have allergy, is approximately 10% and reaches 20–30% in those with an allergic first-degree relative. Intestinal microbiota may modulate immunologic and inflammatory systemic responses and, thus, influence development of sensitization and allergy. Probiotics have been reported to modulate immune responses and their supplementation has been proposed as a preventive intervention.